Key Financial Data Of Group

Oncolys BioPharma Inc. - Filing #7712866

Concept 2017-04-01 to
2017-06-30
2017-01-01 to
2017-06-30
As at
2017-06-30
As at
2016-12-31
2016-01-01 to
2016-12-31
2016-04-01 to
2016-06-30
As at
2016-06-30
2016-01-01 to
2016-06-30
Key financial data of group
Business results of group
Net sales
19,904,000 JPY
178,313,000 JPY
44,680,000 JPY
Ordinary profit (loss)
-517,038,000 JPY
-864,241,000 JPY
-416,970,000 JPY
Net assets
3,044,840,000 JPY
2,617,383,000 JPY
3,064,561,000 JPY
Total assets
3,602,743,000 JPY
3,140,313,000 JPY
3,581,867,000 JPY
Basic earnings (loss) per share
-27.94
-53.89
-101.18
-25.23
-45.51
Diluted earnings per share
Equity-to-asset ratio
0.841 xbrli:pure
0.827 xbrli:pure
0.854 xbrli:pure
Net cash provided by (used in) operating activities
-519,460,000 JPY
-903,424,000 JPY
-385,732,000 JPY
Net cash provided by (used in) investing activities
343,218,000 JPY
256,627,000 JPY
-121,120,000 JPY
Net cash provided by (used in) financing activities
1,042,018,000 JPY
6,423,000 JPY
6,200,000 JPY
Cash and cash equivalents
2,277,291,000 JPY
1,418,993,000 JPY
1,547,225,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.